ICD-10-CM Billable Code

C71.3

Malignant neoplasm of parietal lobe

Clinical Classification Guidelines

Medical Intelligence & Overview

A malignant neoplasm of the parietal lobe is a type of brain cancer that originates in the parietal lobe of the brain. The parietal lobe is responsible for processing sensory information, spatial awareness, and coordination. When a malignant tumor develops in this area, it can interfere with these functions and cause various neurological symptoms. This condition is classified under the ICD-10 code C71.3 and requires medical evaluation for proper diagnosis and treatment planning.

Causes & Symptoms

Clinical Causes: Genetic mutations that lead to uncontrolled cell growth in brain tissue Exposure to high doses of radiation or certain carcinogens A history of prior brain tumors or cancer treatments Unknown factors, as many cases occur without clear risk factors

Key Symptoms: Persistent headaches, often worse in the morning Sudden or gradual weakness or numbness in parts of the body Difficulty with coordination, balance, or spatial awareness Changes in sensation, such as tingling or reduced touch sensitivity Speech or language difficulties, including slurred speech or difficulty understanding language Visual disturbances, such as blurred vision or visual field loss Cognitive or personality changes, including confusion or memory problems Seizures, which may be new or different from previous episodes

Diagnostic & Treatment

Diagnosis Path: Diagnosing a malignant tumor of the parietal lobe involves several steps. Medical professionals typically perform neurological examinations to assess sensory and motor functions. Imaging studies play a vital role, including MRI scans and CT scans, which provide detailed views of brain structures. A biopsy may be necessary to confirm the tumor's malignant nature and determine its type. Additional tests, such as molecular or genetic analysis, can help guide treatment options and prognosis.

Treatment Protocols: Treatment strategies depend on the tumor's size, location, and overall health of the patient. Common approaches include: - Surgery: Removing as much of the tumor as safely possible to alleviate symptoms and obtain tissue for diagnosis. - Radiation therapy: Targeted beams of radiation to destroy cancer cells or shrink the tumor. - Chemotherapy: Use of drugs to kill or inhibit growth of cancer cells, often administered systemically or directly to the tumor site. - Targeted therapy: Medications designed to target specific molecular characteristics of the tumor. - Supportive care: Managing symptoms and maintaining quality of life through medications, physical therapy, and other supportive measures. Multidisciplinary teams work together to develop personalized treatment plans, considering the patient's overall health and preferences.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C71.3 a billable ICD-10 code?
Yes, C71.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C71.3?
Clinical documentation must specify the nature of Malignant neoplasm of parietal lobe and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

neoplasm parietal malignant